ACE and hydrops fetalis: HFpEF may constitute as much as 70% of all HF cases [141, 142], and unlike those with HF with reduced ejection fraction (HFrEF), these patients, the majority of whom are older and female, do not respond as well to routine treatment (e.g. angiotensin-converting enzyme inhibitors) [143].